SIMCERE PHARMAC (Germany) Performance
| S2P Stock | EUR 0.81 0.01 1.22% |
On a scale of 0 to 100, SIMCERE PHARMAC holds a performance score of 5. The entity has a beta of 0.0068, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SIMCERE PHARMAC's returns are expected to increase less than the market. However, during the bear market, the loss of holding SIMCERE PHARMAC is expected to be smaller as well. Please check SIMCERE PHARMAC's sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether SIMCERE PHARMAC's existing price patterns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in SIMCERE PHARMAC GRP are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, SIMCERE PHARMAC reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Price Earnings Ratio | 26.2 | |
| Dividend Yield | 0.0182 | |
| Payout Ratio | 0.3848 |
SIMCERE |
SIMCERE PHARMAC Relative Risk vs. Return Landscape
If you would invest 72.00 in SIMCERE PHARMAC GRP on September 26, 2024 and sell it today you would earn a total of 9.00 from holding SIMCERE PHARMAC GRP or generate 12.5% return on investment over 90 days. SIMCERE PHARMAC GRP is currently producing 0.23% returns and takes up 3.0616% volatility of returns over 90 trading days. Put another way, 27% of traded stocks are less volatile than SIMCERE, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SIMCERE PHARMAC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SIMCERE PHARMAC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SIMCERE PHARMAC GRP, and traders can use it to determine the average amount a SIMCERE PHARMAC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0751
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | S2P | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.06 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 5 95% of assets perform better |
Based on monthly moving average SIMCERE PHARMAC is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SIMCERE PHARMAC by adding it to a well-diversified portfolio.
SIMCERE PHARMAC Fundamentals Growth
SIMCERE Stock prices reflect investors' perceptions of the future prospects and financial health of SIMCERE PHARMAC, and SIMCERE PHARMAC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SIMCERE Stock performance.
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0344 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.1 % | |||
| Shares Outstanding | 2.66 B | |||
| Revenue | 5.58 B | |||
| EBITDA | 743.59 M | |||
| Book Value Per Share | 2.31 X | |||
| Earnings Per Share | 0.05 X | |||
About SIMCERE PHARMAC Performance
By analyzing SIMCERE PHARMAC's fundamental ratios, stakeholders can gain valuable insights into SIMCERE PHARMAC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SIMCERE PHARMAC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SIMCERE PHARMAC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about SIMCERE PHARMAC GRP performance evaluation
Checking the ongoing alerts about SIMCERE PHARMAC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SIMCERE PHARMAC GRP help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SIMCERE PHARMAC GRP has some characteristics of a very speculative penny stock | |
| SIMCERE PHARMAC GRP had very high historical volatility over the last 90 days | |
| About 69.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing SIMCERE PHARMAC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SIMCERE PHARMAC's stock is overvalued or undervalued compared to its peers.
- Examining SIMCERE PHARMAC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SIMCERE PHARMAC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SIMCERE PHARMAC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SIMCERE PHARMAC's stock. These opinions can provide insight into SIMCERE PHARMAC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for SIMCERE Stock analysis
When running SIMCERE PHARMAC's price analysis, check to measure SIMCERE PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SIMCERE PHARMAC is operating at the current time. Most of SIMCERE PHARMAC's value examination focuses on studying past and present price action to predict the probability of SIMCERE PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SIMCERE PHARMAC's price. Additionally, you may evaluate how the addition of SIMCERE PHARMAC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |